Form 8-K - Current report:
SEC Accession No. 0001641172-25-015067
Filing Date
2025-06-13
Accepted
2025-06-13 16:05:49
Documents
16
Period of Report
2025-06-06
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 41245
2 EX-3.1 ex3-1.htm EX-3.1 934
3 GRAPHIC ex99-1_001.jpg GRAPHIC 274457
  Complete submission text file 0001641172-25-015067.txt   638792

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE paxmedicacom-20250606.xsd EX-101.SCH 3475
5 XBRL DEFINITION FILE paxmedicacom-20250606_def.xml EX-101.DEF 2842
6 XBRL LABEL FILE paxmedicacom-20250606_lab.xml EX-101.LAB 50097
7 XBRL PRESENTATION FILE paxmedicacom-20250606_pre.xml EX-101.PRE 33641
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3815
Mailing Address 303 SOUTH BROADWAY, SUITE 125 TARRYTOWN NY 10591
Business Address 303 SOUTH BROADWAY, SUITE 125 TARRYTOWN NY 10591 914-987-2876
PaxMedica, Inc. (Filer) CIK: 0001811623 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41475 | Film No.: 251046498
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)